Viewing Study NCT01998334


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2025-12-28 @ 9:13 PM
Study NCT ID: NCT01998334
Status: UNKNOWN
Last Update Posted: 2013-11-28
First Post: 2013-11-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis
Sponsor: Ruijin Hospital
Organization:

Study Overview

Official Title: Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis
Status: UNKNOWN
Status Verified Date: 2013-11
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Systemic Inflammatory response syndrome(SIRS) is common in patients with severe acute pancreatitis (SAP) in early stage. Continuous Blood Purification (CBP), especially Continuous Veno-Venous Hemofiltration(CVVH) is proved to have an important role in SAP patients to control SIRS. But the detail treatment for this is controversial. In this study, the investigators aim to evaluate the different effects of three kinds of treatment protocols which is CVVH 6h,continuous venovenous hemodiafiltration(CVVHDF) 6h,CVVH 10h for first three days in SAP patients. Compare the vital sign, SIRS parameters, and others between these three groups. This study will try to find a better way for CBP in patients with SAP
Detailed Description: Condition Severe Acute Pancreatitis

Intervention CVVH 6 hours for first three days CVVH 10 hours for first three days CVVHDF 6 hours for first three days

All therapeutic volume is 45ml/kg.h, Device: Braxter HF 1200

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
12411950500 OTHER_GRANT Science and Technology Commission of Shanghai Municipality View